Welltower Inc. (WELL) Guidance & Earnings Results

On 2026-07-27 Welltower Inc. raised guidance: "FY2026 normalized FFO per diluted share raised to $6.36-$6.44 from $6.21-$6.35; FY2026 net income per diluted share revised to $3.11-$3.19 from $3.24-$3.38; FY2026 blended SSNOI growth 13.75%-16.00% (SHO 18.5%-21.5%, SH…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

WELLWelltower Inc.Follow WELL — free

REIT - Healthcare Facilities · Real Estate

—

Price chart with a free account

Market cap: 171.0B
P/E TTM: 109.4
Dividend yield: 1.2%
52-week: —
Next earnings: 26 Oct, in 2 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
27 Jul 26	Raised	FY2026 normalized FFO per diluted share raised to $6.36-$6.44 from $6.21-$6.35; FY2026 net income per diluted share revised to $3.11-$3.19 from $3.24-$3.38; FY2026 blended SSNOI growth 13.75%-16.00% (SHO 18.5%-21.5%, SH triple-net 3.5%-4.5%, OM 2.0%-3.0%, LT/Post-Acute 2.0%-3.0%); G&A ~$265M-$270M; stock-based comp ~$60M; pro rata dispositions $1.1B at 6.8% yield · full year
28 Apr 26	Raised	FY2026 net income raised to $3.24-$3.38 from $3.11-$3.27; normalized FFO raised to $6.21-$6.35 from $6.09-$6.25; SSNOI growth 12.25%-16.00% · full year
28 Jul 25	Raised	FY25 net income per diluted share raised to $1.86-$1.94 from $1.70-$1.84; FY25 normalized FFO per diluted share raised to $5.06-$5.14 from $4.90-$5.04; FY25 SSNOI growth expected 11.25%-13.25% (SHO 18.5%-21.5%, Triple-net 3.5%-4.5%, Outpatient Medical 2.0%-3.0%, Long-Term/Post-Acute Care 2.0%-3.0%); G&A ~$243M-$249M; stock-based comp ~$52M; development funding ~$212M; disposition proceeds ~$340M a · full year

Welltower Inc. — questions

What guidance did Welltower Inc. give?: On 2026-07-27: "FY2026 normalized FFO per diluted share raised to $6.36-$6.44 from $6.21-$6.35; FY2026 net income per diluted share revised to $3.11-$3.19 from $3.24-$3.38; FY2026 blended SSNOI growth 13.75%-16.00% (SHO 18.5%-21.5%, SH triple-net 3.5%-4.5%, OM 2.0%-3.0%, LT/Post-Acute 2.0%-3.0%); G&A ~$265M-$270M; "
When does Welltower Inc. report earnings?: Welltower Inc.'s next earnings report is expected on 2026-10-26.

Every figure on this page comes from Welltower Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.